BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17442231)

  • 1. Treatment of advanced soft tissue sarcoma: conventional agents and promising new drugs.
    Wagner A
    J Natl Compr Canc Netw; 2007 Apr; 5(4):401-10. PubMed ID: 17442231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and advancing systemic treatment options for soft tissue sarcomas.
    Harris SJ; Benson C; Jones RL
    Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapies in soft tissue sarcoma.
    Vincenzi B; Frezza AM; Santini D; Tonini G
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):237-48. PubMed ID: 20465449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
    Aragon-Ching JB; Maki RG
    Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of chemotherapy in patients with soft tissue sarcomas.
    Maki RG
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):229-36. PubMed ID: 15056053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
    Riedel RF
    Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions.
    Aranha O; Agulnik M
    Expert Opin Ther Targets; 2008 Feb; 12(2):197-207. PubMed ID: 18208368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Targeted therapies in soft-tissue and visceral sarcomas].
    Emile JF
    Ann Pathol; 2009 Nov; 29 Spec No 1():S81-2. PubMed ID: 19887262
    [No Abstract]   [Full Text] [Related]  

  • 9. Overview of « druggable » alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies.
    Penel N; Lebellec L; Blay JY; Robin YM
    Crit Rev Oncol Hematol; 2020 Jun; 150():102960. PubMed ID: 32320927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of new chemotherapy agents in soft tissue sarcoma.
    von Mehren M
    J Natl Compr Canc Netw; 2005 Mar; 3(2):198-205. PubMed ID: 19817029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy in adult soft tissue sarcoma.
    Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
    Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of metastatic soft tissue sarcoma].
    Le Cesne A
    Presse Med; 1995 Sep; 24(26):1214-20. PubMed ID: 7567851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
    Ryan CW; Desai J
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
    Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
    Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.
    Mita MM; Gong J; Chawla SP
    Expert Rev Clin Pharmacol; 2013 Sep; 6(5):465-82. PubMed ID: 23971829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for pediatric soft-tissue sarcomas.
    Casanova M; Ferrari A
    Expert Opin Pharmacother; 2011 Mar; 12(4):517-31. PubMed ID: 21306288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical therapy in paediatric soft tissue tumors].
    Orbach D; Levy D; Héritier S; Normand C
    Arch Pediatr; 2010 Jun; 17(6):719-20. PubMed ID: 20654858
    [No Abstract]   [Full Text] [Related]  

  • 19. Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas.
    Casali PG
    Ann Oncol; 2012 Sep; 23 Suppl 10():x167-9. PubMed ID: 22987955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group.
    Verweij J; Lee SM; Ruka W; Buesa J; Coleman R; van Hoessel R; Seynaeve C; di Paola ED; van Glabbeke M; Tonelli D; Judson IR
    J Clin Oncol; 2000 May; 18(10):2081-6. PubMed ID: 10811673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.